Letter regarding the article “Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis”

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Winter M-P, Sulzgruber P, Koller L, Bartko P, Goliasch G, Niessner A (2018) Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis. Heart Fail Rev 23:573–581. https://doi.org/10.1007/s10741-018-9709-9

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO III, Alling D, Wittes JT, Ferrans VJ, Rodriguez ER, Fauci AS (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321:1061–1068. https://doi.org/10.1056/NEJM198910193211601

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM (1989) Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. Am Heart J 117:876–882. https://doi.org/10.1016/0002-8703(89)90626-1

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Imanaka-Yoshida K (2020) Inflammation in myocardial disease: from myocarditis to dilated cardiomyopathy. Pathol Int 70:1–11. https://doi.org/10.1111/pin.12868

    Article  PubMed  Google Scholar 

  5. 5.

    Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska Ġ, Wilczewski P, Niklewski T, Zembala M, Poloński L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45. https://doi.org/10.1161/01.cir.104.1.39

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995–2002. https://doi.org/10.1093/eurheartj/ehp249

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Mason JW, O’Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med 333:269–275. https://doi.org/10.1056/NEJM199508033330501

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Schultheiss H-P, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG (2019) Dilated cardiomyopathy. Nat Rev Dis Primers 5:32. https://doi.org/10.1038/s41572-019-0084-1

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Caforio ALP, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 34:2636-2648–2648a-2648d. https://doi.org/10.1093/eurheartj/eht210

    Article  Google Scholar 

  10. 10.

    Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio ALP, Charron P (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37:1850–1858. https://doi.org/10.1093/eurheartj/ehv727

    Article  PubMed  Google Scholar 

  11. 11.

    Caforio ALP (2020) Myocarditis: pathogenesis, Diagnosis and Treatment. Springer International Publishing

  12. 12.

    Maisch B, Alter P (2018) Treatment options in myocarditis and inflammatory cardiomyopathy : focus on i. v. immunoglobulins. Herz 43:423–430. https://doi.org/10.1007/s00059-018-4719-x

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The study was supported by the Government contract of the Russian Federation with the Institute of Immunology and Physiology (AAAA-A18-118020690020-1).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alexey Sarapultsev.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sarapultsev, A., Kashtalap, V. & Sarapultsev, P. Letter regarding the article “Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis”. Heart Fail Rev (2020). https://doi.org/10.1007/s10741-020-09999-9

Download citation